Sterile Resorbable Collagen Sheets for Operating Rooms

Read Time:5 Minute, 25 Second

Understanding the Clinical Need for Sterile Resorbable Collagen in the OR

Surgical operating rooms require wound management materials that minimize secondary trauma while actively supporting tissue repair. Chronic wound stalling—commonly seen in diabetic foot ulcers and venous leg ulcers—along with dead space in tunneling wounds and excess matrix metalloproteinases (MMPs) in chronic wounds, remains a persistent challenge in both human clinical settings and veterinary soft tissue surgery. These conditions can delay the transition from the inflammatory phase to active granulation, prolonging total wound closure duration. Addressing this gap requires a dressing material that is biocompatible, resorbable, and capable of binding destructive MMPs while providing structural support for new tissue growth.

Roosin Medical Co., Ltd., established in 1996, has positioned itself around this exact industry pain point. The company is specialized in the research, manufacturing, and global distribution of professional advanced wound care and emergency trauma solutions, operating under the stated value of "Better Roosin, Better Life," with the aim of improving patient quality of life through pain reduction and clinical-grade efficacy.

Roosin Medical's Collagen Dressing: Sheet and Powder Formats for Surgical Use

The Collagen Dressing (Sheet & Powder – Human & Veterinary Care) is built around pure Type I bovine collagen that binds excess MMPs to jumpstart stalled healing across human clinical ulcers and veterinary soft tissue wounds, including canine, feline, and equine cases. This dual-format design directly addresses two distinct surgical and chronic wound scenarios: surface coverage and deep cavity management.

The sheet format is intended for surface application, covering open wounds and extensive skin tears or degloving defects with a protective collagen matrix. The powder format, by contrast, is designed for deep cavity application, allowing clinicians to easily pack and obliterate dead space in tunneling wounds, bite tracts, and deep subcutaneous pockets. Because the material is biocompatible and resorbable, it is completely absorbed by native tissue, which eliminates secondary trauma that would otherwise result from dressing removal—an important consideration in sterile surgical environments where minimizing mechanical disruption to healing tissue is a priority.

Key Features Supporting Operating Room Workflows

Pure Type I bovine collagen acts as a bioactive substrate that binds excess MMPs to restart the natural healing cascade in both human and veterinary tissue beds.
The sheet format allows surface-level coverage of open wounds.
The powder format enables packing of dead space in tunneling wounds and deep pockets, a scenario frequently encountered in post-surgical cavity management.
The biocompatible, resorbable structure functions as a natural structural scaffold, guiding cellular ingrowth and accelerating granulation without requiring removal.

Technical Compliance and Quality Assurance

47a0fead26013514546da7afc7b8f179

The Collagen Dressing supports US FDA 510(k) clearance and is compliant with global veterinary medical device manufacturing and ISO 13485 quality standards. This dual compliance reflects Roosin Medical's broader certification portfolio, which includes EU MDR clearance through TÜV Rheinland, ISO 13485:2016 and MDSAP compliance verified by BSI, EC Certificate 93/42/EEC Annex II for wound dressings, EN ISO 13485:2016 Quality Management System certification, and US FDA Facility Registration under 21 CFR 807. The company's products have also received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) and PMDA for medical device marketing and distribution, alongside ISO 11137 and ISO 11135 sterilization validation standards—factors directly relevant to any sterile product intended for operating room use.

Clinical Evidence and Case Outcomes

In chronic ulcer management, Collagen Powder has been used to obliterate dead space in tunneling diabetic foot ulcers, directly addressing the dead space problem that otherwise impedes healing progression. In veterinary trauma and cavity repair settings, Collagen Powder has been applied to pack and obliterate deep dead space in infected canine bite wounds and equine puncture lacerations, helping prevent abscess recurrence and promoting rapid, level tissue regeneration.

Within hospital transition scenarios, Collagen Dressings have been implemented in cases involving stalled healing in deep or tunneling pressure injuries (Stage 3 and 4) and chronic ulcers caused by excessive MMPs and dead space in tissue cavities. The documented business impact includes an accelerated transition from the inflammatory phase to active granulation, successful obliteration of tunneling dead space, and a marked reduction in total wound closure duration. These outcomes illustrate how the dual sheet-and-powder approach can be applied across both surface wounds and deep cavity defects within a single clinical pathway, including surgical operating room settings and veterinary specialty hospitals.

Manufacturing Strength Behind Roosin Medical's Collagen Portfolio

Consistency and sterility in collagen dressing production depend heavily on manufacturing environment and process control. Roosin Medical operates a 10,000 square meter facility equipped with ISO Class 7/8 cleanrooms and automated production, supporting the sterile manufacturing requirements associated with dressings intended for surgical operating rooms and veterinary surgical suites. This manufacturing capability is paired with a dual R&D footprint across Shanghai and Taizhou, where teams have accumulated 30 years of technical expertise in functional dressing lines and biomaterials, including the Type I bovine collagen technology underlying this product line.

The company's broader differentiated advantages also include an atraumatic technology focus, centered on materials such as silicone contact layers designed to protect newly formed granulation tissue—an approach that complements the resorbable, non-removal design of the collagen sheet and powder formats.

Global Reach and Delivery Model

The Collagen Dressing is supplied as a physical product in sterile medical dressing sheet and sterile powder vial or bottle formats, distributed through healthcare procurement channels, veterinary surgical supply networks, and clinical distributor channels. This distribution model supports Roosin Medical's global business coverage, which spans exports to 87 countries, with the United States representing 40% of market focus and Europe representing 30%, alongside additional markets such as Japan.

Industry adaptation for this product line extends across chronic wound care settings—particularly diabetic foot and venous leg ulcer management—surgical operating rooms, veterinary specialty hospitals for canine and feline surgery, equine clinics, and animal trauma centers. This breadth reflects the company's stated strategic positioning as a specialized manufacturer and global distributor of advanced wound care and emergency trauma solutions, supported by OEM/ODM manufacturing flexibility for healthcare procurement teams and distributors seeking tailored supply arrangements.

For operating room teams and wound care clinicians evaluating sterile, resorbable collagen options, Roosin Medical's Collagen Dressing (Sheet & Powder) offers a documented combination of regulatory clearances, cleanroom-manufactured consistency, and case-based evidence addressing dead space obliteration and MMP-related healing stalls—factors that remain central to decision-making in both human surgical and veterinary surgical environments.

https://www.roosin.com/
Roosin Medical Co., Ltd.